Ovation licenses Xenazine

XENAZINE (Tetrabenazine) 12.5mg, 25mg tablets from Ovation Pharmaceuticals
XENAZINE (Tetrabenazine) 12.5mg, 25mg tablets from Ovation Pharmaceuticals

Ovation has acquired the commercial rights to Xenazine (tetrabenazine tablets) from Prestwick for the treatment of chorea associated with Huntington's disease (HD).

Xenazine, a monoamine depletor, is expected to be available by the end of the year in 12.5mg and 25mg dosage strengths.

For more information call (847) 282-1000 or visit www.ovationpharma.com.